Truls Erik Bjerklund Johansen

  • Professor emeritus of urology
  • +47 918 41 063

Short CV, Oct 2023

Truls E. Bjerklund Johansen is professor emeritus of urology at the University of Oslo, Norway and emeritus consultant urologist at the Urology Department, Oslo University Hospital in Norway. He is former chairman of the Urology Department, Aarhus University Hospital in Denmark. He is now consultant urologist at Telemark Hospital Trust in Norway.

He was professor in medicine (urology) and chairman of the Norwegian Institute of Urology at University of Tromsoe, Norway 1993-2001, and served as visiting professor at The Norwegian Cancer Registry and professor in medical science at Telemark University College, Norway until he became ass. professor in urology at the University of Aarhus, Denmark 2007-2012. He is also emeritus associate professor in experimental urological surgery at the Institute of Clinical Medicine, University of Aarhus, Denmark. Bjerklund Johansen has a broad field of interests in urology with urogenital infections and minimally invasive treatment of prostate and renal cancer being his main clinical and research interests.

He has chaired national and international projects related to education, research and organization of health care, and has authored and edited more than 350 articles, book chapters, and books and serves as referee/ consulting editor for many medical journals. He is former Member of ECDC advisory committee on antibiotic resistance.

He holds membership of several urological associations and is honorary member of the Hungarian Association of Urology and the European Section of Infections in Urology (a full section of the European Association of Urology (EAU)). He is fellow of the Royal Society of Medicine, UK and Fellow of the Royal College of Surgeons, Eng.

 

Publications 2024

Tandogdu Z, Koves B, Ristovski S, Balci MBC, Rennesund K, Gravas S, Nale D, Medina-Polo J, Garabášová MK, Costantini E, Cano-Valasco J, Glavinova MS, Bruyere F, Perepanova T, Kulchavenya E, Cek M, Wagenlehner F, Johansen TEB, SERPENS Investigators (2024)
Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study
World J Urol, 42 (1), 314
DOI 10.1007/s00345-024-04979-2, PubMed 38730089

Publications 2023

Cai T, Anceschi U, Prata F, Collini L, Brugnolli A, Migno S, Rizzo M, Liguori G, Gallelli L, Wagenlehner FME, Johansen TEB, Montanari L, Palmieri A, Tascini C (2023)
Artificial Intelligence Can Guide Antibiotic Choice in Recurrent UTIs and Become an Important Aid to Improve Antimicrobial Stewardship
Antibiotics (Basel), 12 (2)
DOI 10.3390/antibiotics12020375, PubMed 36830285

Cai T, Verze P, Arcaniolo D, Pandolfo SD, Smarrazzo F, Manfredi C, Tascini C, Caciagli P, Lanzafame M, De Sio M, Wagenlehner F, Johansen TEB, Palmieri A (2023)
Antibiotic Resistance Patterns Among Uropathogens in Female Outpatients Affected by Uncomplicated Cystitis: Focus on Fosfomycin Trometamol
Int J Antimicrob Agents, 62 (5), 106974
DOI 10.1016/j.ijantimicag.2023.106974, PubMed 37739241

Falkensammer E, Erenler E, Johansen TEB, Tzelves L, Schneidewind L, Yuan Y, Cai T, Koves B, Tandogdu Z (2023)
Antimicrobial Prophylaxis in Robot-Assisted Laparoscopic Radical Prostatectomy: A Systematic Review
Antibiotics (Basel), 12 (12)
DOI 10.3390/antibiotics12121744, PubMed 38136777

Johansen TEB, Zahl PH (2023)
[Is it better not to perform a PSA test?]
Tidsskr Nor Laegeforen, 143 (8)
DOI 10.4045/tidsskr.23.0248, PubMed 37254991

Johansen TEB, Zahl PH (2023)
[T.E.B. Johansen and P.H. Zahl respond]
Tidsskr Nor Laegeforen, 143 (12)
DOI 10.4045/tidsskr.23.0531, PubMed 37668126

Johansen TEB, Zahl PH (2023)
[T.E.B. Johansen and P.H. Zahl respond]
Tidsskr Nor Laegeforen, 143 (12)
DOI 10.4045/tidsskr.23.0529, PubMed 37668128

Schneidewind L, Kiss B, Stangl FP, Tandogdu Z, Wagenlehner FME, Johansen TEB, Köves B, Medina-Polo J, Tapia AM, Kranz J (2023)
Practice Patterns in Fournier's Gangrene in Europe and Implications for a Prospective Registry Study
Antibiotics (Basel), 12 (2)
DOI 10.3390/antibiotics12020197, PubMed 36830108

Stangl FP, Schneidewind L, Kiss B, Kranz J, Wagenlehner FM, Johansen TEB, Köves B, Medina-Polo J, Tapia AM, Tandogdu Z (2023)
Non-Antibiotic Prophylaxis for Recurrent UTIs in Neurogenic Lower Urinary Tract Dysfunction (NAPRUN): Study Protocol for a Prospective, Longitudinal Multi-Arm Observational Study
Methods Protoc, 6 (3)
DOI 10.3390/mps6030052, PubMed 37367996

Publications 2022

Cai T, Privitera S, Trovato F, Capogrosso P, Dehò F, Cimino S, Rizzo M, Liguori G, Salonia A, Palmieri A, Verze P, Johansen TEB (2022)
A Proposal of a New Nomogram to Predict the Need for Testosterone ReplACEment (TRACE): A Simple Tool for Everyday Clinical Practice
J Pers Med, 12 (10)
DOI 10.3390/jpm12101654, PubMed 36294793

Johansen TEB, Cai T (2022)
Facing urosepsis- the most deadly of all urological diseases
Scand J Urol, 56 (5-6), 421-422
DOI 10.1080/21681805.2022.2137230, PubMed 36314558

Publications 2021

Cai T, Gallelli L, Cione E, Perletti G, Ciarleglio F, Malossini G, De Pretis G, Palmieri A, Mirone V, Bartoletti R, Johansen TEB (2021)
The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study
World J Urol, 39 (9), 3433-3440
DOI 10.1007/s00345-020-03580-7, PubMed 33442769

Cakir OO, Castiglione F, Tandogdu Z, Collins J, Alnajjar HM, Akers C, Albersen M, Alifrangis C, Ayres B, Brouwer O, Cullen I, Hawkey P, Jakobsen JK, Johansen TEB, Kalejaiye O, Kaul A, Köves B, Kumar V, Mancini M, Mitra AV, Parnham A, Pozzi E, Protzel C, Sangar VK, Wagenlehner F et al. (2021)
Management of penile cancer patients during the COVID-19 pandemic: An eUROGEN accelerated Delphi consensus study
Urol Oncol, 39 (3), 197.e9-197.e17
DOI 10.1016/j.urolonc.2020.12.005, PubMed 33397593

Gjersvik P, Heikkila R, Johansen TEB (2021)
Rescue treatment for cancer
Tidsskr. Nor. Laegeforen., 141 (5), 487

Johansen TEB, Cai T, Naber K, Nicolle LE, Tandogdu Z, Tonjum T, Wagenlehner F, Zahl PH, Koves B (2021)
Pregnant women should be screened for asymptomatic bacteriuria
Tidsskr. Nor. Laegeforen., 141 (11), 1046-1048

Johansen TEB, Cai T, Naber K, Nicolle LE, Tandogdu Z, Tønjum T, Wagenlehner F, Zahl PH, Koves B (2021)
[Pregnant women should be screened for asymptomatic bacteriuria]
Tidsskr Nor Laegeforen, 141 (11)
DOI 10.4045/tidsskr.21.0379, PubMed 34423934

Publications 2020

Berger I, Berland S, Rodriguez JR, Aamodt H, Sitek JC, Jørgensen K, Johansen TEB (2020)
[Birt-Hogg-Dubé syndrome]
Tidsskr Nor Laegeforen, 140 (6)
DOI 10.4045/tidsskr.18.0848, PubMed 32321218

Berger I, Aamodt H, Jorgensen K, Berland S, Sitek JC, Johansen TEB, Rodriguez JR (2020)
Birt-Hogg-Dube-syndrome
Tidsskr. Nor. Laegeforen., 140 (6), 565-569

Cai T, Tamanini I, Mattevi D, Verze P, Palmieri A, Malossini G, Mirone V, Novelli A, Tascini C, Johansen TEB (2020)
Fosfomycin trometamol and N-acetyl-L-cysteine as combined oral therapy of difficult-to-treat chronic bacterial prostatitis: Results of a pilot study
Int J Antimicrob Agents, 56 (1), 105935
DOI 10.1016/j.ijantimicag.2020.105935, PubMed 32156620

Publications 2019

Johansen TEB, Zahl PH, Baco E, Bartoletti R, Bonkat G, Bruyere F, Cai T, Cek M, Kulchavenya E, Köves B, Mouraviev V, Pilatz A, Tandogdu Z, Tenke P, Wagenlehner FME (2019)
Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry
World J Urol, 38 (1), 17-26
DOI 10.1007/s00345-019-02837-0, PubMed 31183524

Tandogdu Z, Koves B, Cai T, Cek M, Tenke P, Naber K, Wagenlehner F, Johansen TEB (2019)
Condition-specific surveillance in health care-associated urinary tract infections as a strategy to improve empirical antibiotic treatment: an epidemiological modelling study
World J Urol, 38 (1), 27-34
DOI 10.1007/s00345-019-02963-9, PubMed 31555835

Publications 2018

Kløw NE, Grøtta OJ, Bay D, Sandbæk G, Johansen TEB, Hagen T, Baco E (2018)
Outcome after prostatic artery embolization in patients with symptomatic benign prostatic hyperplasia
Acta Radiol, 60 (9), 1175-1180
DOI 10.1177/0284185118813709, PubMed 30450921

Publications 2017

Cai T, Koves B, Johansen TE (2017)
Asymptomatic bacteriuria, to screen or not to screen - and when to treat?
Curr Opin Urol, 27 (2), 107-111
DOI 10.1097/MOU.0000000000000368, PubMed 27906777

McDonald M, Kameh D, Johnson ME, Johansen TEB, Albala D, Mouraviev V (2017)
A Head-to-Head Comparative Phase II Study of Standard Urine Culture and Sensitivity Versus DNA Next-generation Sequencing Testing for Urinary Tract Infections
Rev Urol, 19 (4), 213-220
DOI 10.3909/riu0780, PubMed 29472825

Publications 2016

Bartoletti R, Cai T, Wagenlehner FM, Naber K, Johansen TEB (2016)
Treatment of Urinary Tract Infections and Antibiotic Stewardship
Eur. Urol. Suppl., 15 (4), 81-87
DOI 10.1016/j.eursup.2016.04.003

Cai T, Bonkat G, Tandogdu Z, Bartoletti R, Wagenlehner FME, Grabe M, Johansen TEB (2016)
How to Use Antimicrobial Prophylaxis in Urological Procedures
Eur Urol Focus, 2 (4), 348-350
DOI 10.1016/j.euf.2016.02.010, PubMed 28723464

Cai T, Verze P, Palmieri A, Gacci M, Lanzafame P, Malossini G, Nesi G, Bonkat G, Wagenlehner FM, Mirone V, Bartoletti R, Johansen TE (2016)
Is Preoperative Assessment and Treatment of Asymptomatic Bacteriuria Necessary for Reducing the Risk of Postoperative Symptomatic Urinary Tract Infections After Urologic Surgical Procedures?
Urology, 99, 100-105
DOI 10.1016/j.urology.2016.10.016, PubMed 27773650

Johansen TEB, Naber KG (2016)
Working on a Dream
Eur. Urol. Suppl., 15 (4), 69-70
DOI 10.1016/j.eursup.2016.04.006

Kulchavenya E, Naber K, Johansen TEB (2016)
Urogenital Tuberculosis: Classification, Diagnosis, and Treatment
Eur. Urol. Suppl., 15 (4), 112-121
DOI 10.1016/j.eursup.2016.04.001

Smelov V, Naber K, Johansen TEB (2016)
Improved Classification of Urinary Tract Infection: Future Considerations
Eur. Urol. Suppl., 15 (4), 71-80
DOI 10.1016/j.eursup.2016.04.002

Tandogdu Z, Johansen TEB, Bartoletti R, Wagenlehner F (2016)
Management of the Urologic Sepsis Syndrome
Eur. Urol. Suppl., 15 (4), 102-111
DOI 10.1016/j.eursup.2016.04.004

Vahlensieck W, Perepanova T, Johansen TEB, Tenke P, Naber KG, Wagenlehner FME (2016)
Management of Uncomplicated Recurrent Urinary Tract Infections
Eur. Urol. Suppl., 15 (4), 95-101
DOI 10.1016/j.eursup.2016.04.007

Wagenlehner F, Tandogdu Z, Bartoletti R, Cai T, Cek M, Kulchavenya E, Köves B, Naber K, Perepanova T, Tenke P, Wullt B, Bogenhard F, Johansen TE (2016)
The Global Prevalence of Infections in Urology Study: A Long-Term, Worldwide Surveillance Study on Urological Infections
Pathogens, 5 (1)
DOI 10.3390/pathogens5010010, PubMed 26797640

Publications 2015

Johansen TE (2015)
[Different guidelines for treatment of prostate cancer]
Tidsskr Nor Laegeforen, 135 (10), 924-5
DOI 10.4045/tidsskr.15.0317, PubMed 26037750

Johansen TE (2015)
[Re: Different guidelines for treatment of prostate cancer]
Tidsskr Nor Laegeforen, 135 (17), 1535-6
DOI 10.4045/tidsskr.15.0928, PubMed 26394579

Johansen TE (2015)
[Re: The problematical prostate cancer]
Tidsskr Nor Laegeforen, 135 (17), 1536
DOI 10.4045/tidsskr.15.0915, PubMed 26394580

Tandoğdu Z, Bartoletti R, Cai T, Çek M, Grabe M, Kulchavenya E, Köves B, Menon V, Naber K, Perepanova T, Tenke P, Wullt B, Johansen TE, Wagenlehner F (2015)
Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003-2013
World J Urol, 34 (8), 1193-200
DOI 10.1007/s00345-015-1722-1, PubMed 26658886

Publications 2014

Johansen TE (2014)
Reliable diagnostic work-up of rare urinary infections
Tidsskr Nor Laegeforen, 134 (5), 533
DOI 10.4045/tidsskr.13.1198, PubMed 24621913

Johansen TE, Naber KG (2014)
Urinary Tract Infections
Antibiotics (Basel), 3 (3), 375-7
DOI 10.3390/antibiotics3030375, PubMed 27025751

Nilsson R, Omland H, Dahl AA, Johansen TE (2014)
Early outcome of orchiopexy and analysis of predictive factors: a retrospective study from 2001 to 2010 in a Norwegian regional hospital
Scand J Urol, 48 (5), 474-81
DOI 10.3109/21681805.2014.905631, PubMed 24720831

Rud E, Klotz D, Rennesund K, Baco E, Johansen TE, Diep LM, Svindland A, Eri LM, Eggesbø HB (2014)
Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer
World J Urol, 33 (7), 1015-21
DOI 10.1007/s00345-014-1362-x, PubMed 25059766

Tenke P, Köves B, Johansen TE (2014)
An update on prevention and treatment of catheter-associated urinary tract infections
Curr Opin Infect Dis, 27 (1), 102-7
DOI 10.1097/QCO.0000000000000031, PubMed 24345923

Wagenlehner FM, Pilatz A, Waliszewski P, Weidner W, Johansen TE (2014)
Reducing infection rates after prostate biopsy
Nat Rev Urol, 11 (2), 80-6
DOI 10.1038/nrurol.2013.322, PubMed 24418806

Publications 2011

Johansen TE, Botto H, Cek M, Grabe M, Tenke P, Wagenlehner FM, Naber KG (2011)
Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system
Int J Antimicrob Agents, 38 Suppl, 64-70
DOI 10.1016/j.ijantimicag.2011.09.009, PubMed 22018988

Matsumoto T, Wagenlehner FM, Johansen TE (2011)
Antimicrobial therapy of urinary tract infections
Int J Antimicrob Agents, 38 Suppl, 1-2
DOI 10.1016/j.ijantimicag.2011.09.001, PubMed 22018987

Montvilas P, Solvig J, Johansen TE (2011)
Single-centre review of radiologically guided percutaneous nephrostomy using "mixed" technique: success and complication rates
Eur J Radiol, 80 (2), 553-8
DOI 10.1016/j.ejrad.2011.01.109, PubMed 21353753

Publications 2010

Mouraviev V, Johansen TE, Polascik TJ (2010)
Contemporary results of focal therapy for prostate cancer using cryoablation
J Endourol, 24 (5), 827-34
DOI 10.1089/end.2009.0546, PubMed 20443724

Publications 2008

Johansen TE (2008)
[PSA based screening for prostatic cancer]
Tidsskr Nor Laegeforen, 128 (22), 2612-4
PubMed 19023357

Johansen TE, Berg C (2008)
[Hormone treatment of prostate cancer in Norway]
Tidsskr Nor Laegeforen, 128 (22), 2558-62
PubMed 19023350

Publications 2007

Johansen TE, Istad JA (2007)
Long-term cost analysis of treatment options for benign prostatic hyperplasia in Norway
Scand J Urol Nephrol, 41 (2), 124-31
DOI 10.1080/00365590600911266, PubMed 17454951

Publications 2006

Johansen TE, Cek M, Naber KG, Stratchounski L, Svendsen MV, Tenke P, PEP and PEAP-study investigators, Board of the European Society of Infections in Urology (2006)
Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies
Int J Antimicrob Agents, 28 Suppl 1, S91-107
DOI 10.1016/j.ijantimicag.2006.05.005, PubMed 16829052

Publications 2005

Cek M, Lenk S, Naber KG, Bishop MC, Johansen TE, Botto H, Grabe M, Lobel B, Redorta JP, Tenke P, Members of the Urinary Tract Infection (UTI) Working Group of the European Association of Urology (EAU) Guidelines Office (2005)
EAU guidelines for the management of genitourinary tuberculosis
Eur Urol, 48 (3), 353-62
DOI 10.1016/j.eururo.2005.03.008, PubMed 15982799

Johansen TE (2005)
[Radical therapy for prostate cancer in Norway]
Tidsskr Nor Laegeforen, 125 (12), 1658-60
PubMed 15976834

Johansen TE (2005)
[Cryotherapy for prostate cancer]
Tidsskr Nor Laegeforen, 125 (12), 1661-3
PubMed 15976835

Publications 2004

Johansen TE (2004)
Nosocomially acquired urinary tract infections in urology departments. Why an international prevalence study is needed in urology
Int J Antimicrob Agents, 23 Suppl 1, S30-4
DOI 10.1016/j.ijantimicag.2003.09.003, PubMed 15037326

Johansen TE (2004)
The role of imaging in urinary tract infections
World J Urol, 22 (5), 392-8
DOI 10.1007/s00345-004-0414-z, PubMed 15290204

Publications 2003

Johansen TE (2003)
[Drugs against urinary incontinence]
Tidsskr Nor Laegeforen, 123 (2), 178-9
PubMed 12607502

Johansen TE (2003)
[A public disease without guidelines]
Tidsskr Nor Laegeforen, 123 (17), 2410
PubMed 14508529

Publications 2002

Johansen TE (2002)
[Ritual circumcision]
Tidsskr Nor Laegeforen, 122 (1), 15
PubMed 11851285

Johansen TE (2002)
[Renal cancer in a 20-year perspective]
Tidsskr Nor Laegeforen, 122 (25), 2430
PubMed 12448108

Johansen TE (2002)
[Drugs against symptomatic, benign prostatic hyperplasia]
Tidsskr Nor Laegeforen, 122 (26), 2544-5
PubMed 12522881

Page visits: 2758